Professor Matt Trau
Professor

Matt Trau

Email: 

Background

Professor Matt Trau is currently a Professor of Chemistry at The University of Queensland (UQ); and is also Senior Group Leader and co-founder of the Australian Institute for Bioengineering and Nanotechnology. Since graduating from the University of Sydney (BSc Hons I, University Medal) and the University of Melbourne (PhD in Physical Chemistry, 1993), he has held positions in industry and academia across the globe. These include a Fulbright Research Fellowship at Princeton University, USA; and a research scientist at Dow Chemical and ICI Pty Ltd. Professor Trau has been a Visiting Professor at two of the largest Cancer Research Centres in the world: The Dana Farber Cancer Research Institute, Harvard Medical School, Boston (2000); and the Fred Hutchinson Cancer Research Centre, Seattle (2008). Professor Trau is internationally recognised for his innovative and cross-disciplinary research at the interface between chemistry, nanotechnology, biology and medicine. He has co-authored more than 290 refereed publications, many of which appear in the highest impact journals in his field, e.g., fifteen Science and Nature family publications. His major awards and honours include an ARC Laureate Fellowship, an ARC Federation Fellowship (amoungst the most prestigious scientific fellowships in Australia), a Fulbright Research Fellowship to the USA; a Queensland Young Tall Poppy Award; a UQ Foundation/Vice Chancellor’s Research Excellence Award; a Paul Harris Fellowship; and a Pink Circle Award for breast cancer research excellence.

Availability

Professor Matt Trau is:
Available for supervision
Media expert

Fields of research

Macromolecular and materials chemistry Physical chemistry

Qualifications

  • Bachelor (Honours) of Science (Advanced), University of Sydney
  • Doctor of Philosophy, University of Melbourne

Research impacts

Research

Nanoscience, Nanotechnology, Molecular diagnostics.

Leadership of major multi-disciplinary international programs

Professor Trau has raised more than $22 million in competitive national and international grant funding in the past 10 years. In the last five years, Professor Trau has initiated and led several large international programs that involve close collaboration between leading nanotechnologists, molecular biologists, geneticists and commercial researchers - with the goal of creating cutting edge diagnostics. These include a $4 million National and International Research Alliances Program (NIRAP) grant from the Queensland government ("International Partnership for preventative and Personalised Medicine)"; and two consecutive $5 million multidisciplinary collaborative grants from the National Breast Cancer Foundation (NBCF): "Novel strategies for Prediction and Control of Advanced Breast Cancer via Nanoscaled Epigenetic-Based Biosensors", 2008-2013; and "Enabling Clinical Epigenetic Diagnostics: The Next Generation of Personalized Breast Cancer Care", 2013-2018. These grants involve research collaborations with some of the highest calibre scientists in the world, e.g., Dr Lee Hartwell (2001 Nobel Laureate) from Seattle was a co-chief investigator on the NIRAP grant, and each of the NBCF grants include leading geneticists, pathologists and oncologists from across Australia and around the world. In the past five years, he has been a consultant for a range of national and international companies such as Merck, Digene, Beckman Coulter, Panbio and A.I. Scientific, as well as being the founder and Director of Nanomics BioSystems Pty Ltd (a spinoff company from his laboratory).

Major plenary lectures and international conferences

Since 2003, Professor Trau has presented more than 60 invited plenary/keynote lectures at major international conferences spanning the disciplines of Chemistry, Nanotechnology, Chemical Engineering, Cancer and Diagnostics. Recent examples include: the 4th International NanoBio Conference, (Seattle) 2012; the 14th International Colloid & Surface Science Conference, (Japan) 2012; "Cancer Nanotechnology" Gordon Research Conference, (USA) 2011; the WA Cancer Conference 2011; Sydney Cancer Conference, 2010. In the past 10 years, Professor Trau has played the role of conference convenor, chair, co-chair and symposium chair for 10 major international conferences. Recent examples include: immediate past chair of the 1st International Conference on BioNano Innovation, (Brisbane) 2012; co-chair of the 5th International NanoBio Conference scheduled for Brisbane in 2014.

Search Professor Matt Trau’s works on UQ eSpace

311 works between 1988 and 2025
All (311) Journal Article (272) Book Chapter (11) Conference Publication (26) Book (1) Edited Outputs (1)

1 - 20 of 311 works

2025

Journal Article

Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring

Zhang, Zhen, Wang, Jing, Wuethrich, Alain and Trau, Matt (2025). Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring. National Science Review, 12 (3) nwae452, 1-17. doi: 10.1093/nsr/nwae452

Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring

2024

Journal Article

Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function

Sinclair, Jane E., Vedelago, Courtney, Ryan, Feargal J., Carney, Meagan, Redd, Meredith A., Lynn, Miriam A., Grubor-Bauk, Branka, Cao, Yuanzhao, Henders, Anjali K., Chew, Keng Yih, Gilroy, Deborah, Greaves, Kim, Labzin, Larisa, Ziser, Laura, Ronacher, Katharina, Wallace, Leanne M., Zhang, Yiwen, Macauslane, Kyle, Ellis, Daniel J., Rao, Sudha, Burr, Lucy, Bain, Amanda, Karawita, Anjana, Schulz, Benjamin L., Li, Junrong, Lynn, David J., Palpant, Nathan, Wuethrich, Alain, Trau, Matt and Short, Kirsty R. (2024). Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function. Nature Microbiology, 9 (12), 1-13. doi: 10.1038/s41564-024-01838-z

Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function

2024

Journal Article

Glycan profiling in small extracellular vesicles with a SERS microfluidic biosensor identifies early malignant development in lung cancer

Zhou, Quan, Niu, Xueming, Zhang, Zhen, O'Byrne, Kenneth, Kulasinghe, Arutha, Fielding, David, Möller, Andreas, Wuethrich, Alain, Lobb, Richard J. and Trau, Matt (2024). Glycan profiling in small extracellular vesicles with a SERS microfluidic biosensor identifies early malignant development in lung cancer. Advanced Science, 11 (33) 2401818, 1-12. doi: 10.1002/advs.202401818

Glycan profiling in small extracellular vesicles with a SERS microfluidic biosensor identifies early malignant development in lung cancer

2024

Journal Article

A mesoporous gold sensor unveils phospho PD-L1 in extracellular vesicles as a proxy for PD-L1 expression in lung cancer tissue

Shanmugasundaram, Karthik B., Ahmed, Emtiaz, Miao, Xinzhe, Kulasinghe, Arutha, Fletcher, James A., Monkman, James, Mainwaring, Paul, Masud, Mostafa Kamal, Park, Hyeongyu, Hossain, Md Shahriar A., Yamauchi, Yusuke, Sina, Abu A. I., O’Byrne, Kenneth, Wuethrich, Alain and Trau, Matt (2024). A mesoporous gold sensor unveils phospho PD-L1 in extracellular vesicles as a proxy for PD-L1 expression in lung cancer tissue. ACS Sensors, 9 (6), 3009-3016. doi: 10.1021/acssensors.4c00192

A mesoporous gold sensor unveils phospho PD-L1 in extracellular vesicles as a proxy for PD-L1 expression in lung cancer tissue

2024

Journal Article

Analysis of secreted small extracellular vesicles from activated human microglial cell lines reveals distinct pro‐ and anti‐inflammatory proteomic profiles

Niu, Xueming, Zhang, Zhen, Zhou, Quan, Wuethrich, Alain, Lobb, Richard and Trau, Matt (2024). Analysis of secreted small extracellular vesicles from activated human microglial cell lines reveals distinct pro‐ and anti‐inflammatory proteomic profiles. Proteomics, 24 (11) 2300094, 1-13. doi: 10.1002/pmic.202300094

Analysis of secreted small extracellular vesicles from activated human microglial cell lines reveals distinct pro‐ and anti‐inflammatory proteomic profiles

2024

Journal Article

LowTempGAL: a highly responsive low temperature-inducible GAL system in Saccharomyces cerevisiae

Lu, Zeyu, Shen, Qianyi, Bandari, Naga Chandra, Evans, Samuel, Mcdonnell, Liam, Liu, Lian, Jin, Wanli, Luna-Flores, Carlos Horacio, Collier, Thomas, Talbo, Gert, Mccubbin, Tim, Esquirol, Lygie, Myers, Chris, Trau, Matt, Dumsday, Geoff, Speight, Robert, Howard, Christopher B., Vickers, Claudia E. and Peng, Bingyin (2024). LowTempGAL: a highly responsive low temperature-inducible GAL system in Saccharomyces cerevisiae. Nucleic Acids Research, 52 (12) gkae460, 7367-7383. doi: 10.1093/nar/gkae460

LowTempGAL: a highly responsive low temperature-inducible GAL system in Saccharomyces cerevisiae

2024

Journal Article

Molecular Stratification and Treatment Monitoring of Lung Cancer Using a Small Extracellular Vesicle-Activated Nanocavity Architecture

Li, Junrong, Li, Meiqin, Wuethrich, Alain, Guan, Rui, Zhao, Lihui, Hu, Cong, Trau, Matt and Sun, Yao (2024). Molecular Stratification and Treatment Monitoring of Lung Cancer Using a Small Extracellular Vesicle-Activated Nanocavity Architecture. Analytical Chemistry, 96 (19), 7651-7660. doi: 10.1021/acs.analchem.4c00558

Molecular Stratification and Treatment Monitoring of Lung Cancer Using a Small Extracellular Vesicle-Activated Nanocavity Architecture

2024

Journal Article

A mesoporous gold biosensor to investigate immune checkpoint protein heterogeneity in single lung cancer cells

Ahmed, Emtiaz, Masud, Mostafa Kamal, Komatineni, Prathyusha, Dey, Shuvashis, Lobb, Richard, Hossain, Md Shahriar A., Möller, Andreas, Yamauchi, Yusuke, Sina, Abu Ali Ibn and Trau, Matt (2024). A mesoporous gold biosensor to investigate immune checkpoint protein heterogeneity in single lung cancer cells. Biosensors and Bioelectronics, 249 115984, 1-9. doi: 10.1016/j.bios.2023.115984

A mesoporous gold biosensor to investigate immune checkpoint protein heterogeneity in single lung cancer cells

2024

Journal Article

Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy

Dey, Shuvashis, Kinoshita, Masaki, Puttick, Simon, Rose, Stephen, Trau, Matt, Roberts, Matthew J. and Koo, Kevin M. (2024). Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy. Advanced Sensor Research, 3 (7) 2300193. doi: 10.1002/adsr.202300193

Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy

2024

Journal Article

High accuracy of clinical verification of electrohydrodynamic-driven nanobox-on-mirror platform for molecular identification of respiratory viruses

Li, Junrong, Guan, Rui, Wuethrich, Alain, Yan, Mingzhe, Cheng, Jing, Liu, Guorong, Zhan, Jianbo, Trau, Matt and Sun, Yao (2024). High accuracy of clinical verification of electrohydrodynamic-driven nanobox-on-mirror platform for molecular identification of respiratory viruses. Analytical Chemistry, 96 (11), 4495-4504. doi: 10.1021/acs.analchem.3c05120

High accuracy of clinical verification of electrohydrodynamic-driven nanobox-on-mirror platform for molecular identification of respiratory viruses

2024

Journal Article

Digital platforms enabling single-molecule analysis for cancer detection

Li, Junrong, Zhang, Zhen, Trau, Matt and Wuethrich, Alain (2024). Digital platforms enabling single-molecule analysis for cancer detection. TrAC Trends in Analytical Chemistry, 171 117502, 1-12. doi: 10.1016/j.trac.2023.117502

Digital platforms enabling single-molecule analysis for cancer detection

2024

Journal Article

Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes

Zhou, Quan, Wang, Jing, Zhang, Zhen, Wuethrich, Alain, Lobb, Richard J. and Trau, Matt (2024). Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes. Biosensors and Bioelectronics, 244 115819, 1-10. doi: 10.1016/j.bios.2023.115819

Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes

2024

Journal Article

Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi‐omic analysis

Lane, Rebecca E., Korbie, Darren, Khanna, Kum Kum, Mohamed, Ahmed, Hill, Michelle M. and Trau, Matt (2024). Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi‐omic analysis. Proteomics, 24 (11) e2300089, 1-18. doi: 10.1002/pmic.202300089

Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi‐omic analysis

2024

Journal Article

A perspective about the potential use of nanotechnology to monitor immune correlates of the clinical course of major mood disorders

Wuethrich, Alain, Crouse, Jacob J., Vedelago, Courtney, Zhang, Yiwen, Farokhinejad, Fahimeh, Hickie, Ian B. and Trau, Matt (2024). A perspective about the potential use of nanotechnology to monitor immune correlates of the clinical course of major mood disorders. Research Directions: Depression, 1 e20, 1-4. doi: 10.1017/dep.2024.3

A perspective about the potential use of nanotechnology to monitor immune correlates of the clinical course of major mood disorders

2023

Journal Article

Integration of yeast episomal/integrative plasmid causes genotypic and phenotypic diversity and improved sesquiterpene production in metabolically engineered Saccharomyces cerevisiae

Peng, Bingyin, Weintraub, Sarah J., Lu, Zeyu, Evans, Samuel, Shen, Qianyi, McDonnell, Liam, Plan, Manuel, Collier, Thomas, Cheah, Li Chen, Ji, Lei, Howard, Christopher B., Anderson, Will, Trau, Matt, Dumsday, Geoff, Bredeweg, Erin L., Young, Eric M., Speight, Robert and Vickers, Claudia E. (2023). Integration of yeast episomal/integrative plasmid causes genotypic and phenotypic diversity and improved sesquiterpene production in metabolically engineered Saccharomyces cerevisiae. ACS Synthetic Biology, 13 (1), 141-156. doi: 10.1021/acssynbio.3c00363

Integration of yeast episomal/integrative plasmid causes genotypic and phenotypic diversity and improved sesquiterpene production in metabolically engineered Saccharomyces cerevisiae

2023

Conference Publication

Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC

O'Byrne, K., Shanmugasundaram, K.B., Ahmed, E., Kulasinghe, A., Monkman, J., Fletcher, J.A., Mainwaring, P.N., Masud, M.K., Park, H., Hossain, M.S.A., Yamauchi, Y., Sina, A.A.I., Wuethrich, A. and Trau, M. (2023). Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC. 2023 World Conference on Lung Cancer, Singapore, 9-12 September 2023. New York, NY United States: Elsevier. doi: 10.1016/j.jtho.2023.09.432

Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC

2023

Journal Article

Multiplex SERS-lectin-immunoassay for esophageal adenocarcinoma screening

Khamis, Ramlah, Shanmugasundaram, Karthik B., Zhou, Quan, Lu, Jennifer, Zhang, Zhen, Hill, Michelle M., Sina, Abu Ali Ibn, Trau, Matt and Wuethrich, Alain (2023). Multiplex SERS-lectin-immunoassay for esophageal adenocarcinoma screening. ACS Applied Nano Materials, 6 (21), 20190-20197. doi: 10.1021/acsanm.3c03987

Multiplex SERS-lectin-immunoassay for esophageal adenocarcinoma screening

2023

Journal Article

Profiling proteomics responses to hexokinase-II depletion in terpene-producing Saccharomyces cerevisiae

Lu, Zeyu, Shen, Qianyi, Liu, Lian, Talbo, Gert, Speight, Robert, Trau, Matt, Dumsday, Geoff, Howard, Christopher B., Vickers, Claudia E. and Peng, Bingyin (2023). Profiling proteomics responses to hexokinase-II depletion in terpene-producing Saccharomyces cerevisiae. Engineering Microbiology, 3 (3) 100079, 100079. doi: 10.1016/j.engmic.2023.100079

Profiling proteomics responses to hexokinase-II depletion in terpene-producing Saccharomyces cerevisiae

2023

Journal Article

Erratum: Correction: Plasma extracellular vesicle phenotyping for the differentiation of early-stage lung cancer and benign lung diseases (Nanoscale horizons (2023) 8 6 (746-758))

Yuan, Liwen, Chen, Yanpin, Ke, Longfeng, Zhou, Quan, Chen, Jiayou, Fan, Min, Wuethrich, Alain, Trau, Matt and Wang, Jing (2023). Erratum: Correction: Plasma extracellular vesicle phenotyping for the differentiation of early-stage lung cancer and benign lung diseases (Nanoscale horizons (2023) 8 6 (746-758)). Nanoscale horizons, 8 (9) d3nh90028b, 1288-1289. doi: 10.1039/d3nh90028b

Erratum: Correction: Plasma extracellular vesicle phenotyping for the differentiation of early-stage lung cancer and benign lung diseases (Nanoscale horizons (2023) 8 6 (746-758))

2023

Journal Article

A microfluidic liquid biopsy platform to monitor protein biomarker heterogeneity in single circulating therapy‐resistance cancer cell

Ahmed, Emtiaz, Shanmugasundaram, Karthik Balaji, Li, Junrong, Behren, Andreas, Lobb, Richard, Möller, Andreas, Wuethrich, Alain, Dey, Shuvashis, Sina, Abu Ali Ibn and Trau, Matt (2023). A microfluidic liquid biopsy platform to monitor protein biomarker heterogeneity in single circulating therapy‐resistance cancer cell. Advanced Sensor Research, 2 (12) 2300059. doi: 10.1002/adsr.202300059

A microfluidic liquid biopsy platform to monitor protein biomarker heterogeneity in single circulating therapy‐resistance cancer cell

Current funding

  • 2024 - 2026
    ALL IN - AI and Laboratory Led IdentificatioN of PASC
    NHMRC MRFF Post-Acute Sequelae of COVID-19
    Open grant
  • 2024 - 2028
    Digital chemistry and catalysis: redefining reactions in confined systems
    ARC Australian Laureate Fellowships
    Open grant
  • 2023 - 2027
    Rhythms and blues: Personalising care for body clock dysfunction in mood disorders (NHMRC Synergy grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2022 - 2025
    nanoIMPAC: Monitoring immune toxicities and tumour immune evasion in lung cancer
    Cancer Australia
    Open grant
  • 2021 - 2028
    Immunostorm Chip Research
    Evolution Mining Limited
    Open grant
  • 2021 - 2025
    The amplification of DNA from environmental metazoan cells (enCells)
    CSIRO
    Open grant

Past funding

  • 2022 - 2025
    An integrated nano-bioengineered chip for enhanced molecular evolution
    ARC Discovery Projects
    Open grant
  • 2022 - 2023
    Whole exome and transcriptome profiling of patients with advanced cutaneous squamous cell carcinoma exposed to immunotherapy: C-Seq STUDY (Research Support Scheme Project Grant led by Metro South HHS)
    Metro South Hospital and Health Service
    Open grant
  • 2021 - 2022
    Cannabis genetic marker development for the breeding of medicinal cannabis varieties
    CannaPacific Pty Ltd
    Open grant
  • 2021 - 2023
    Single molecule sensing on nanopillars: Reading complex molecular circuits
    ARC Discovery Projects
    Open grant
  • 2020 - 2022
    Early detection of lung cancer (NHMRC Ideas Grant led by The Council of the Queensland Institute of Medical Research)
    Queensland Institute of Medical Research
    Open grant
  • 2019 - 2022
    The Development and Clinical Translation of Blood-Based Diagnostics for Brain Cancer (Mark Hughes Foundation administered by the University of Newcastle)
    University of Newcastle
    Open grant
  • 2018 - 2021
    Genomics markers in breast cancer
    Queen Mary University of London
    Open grant
  • 2018
    Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2021
    DNA exhibits new self-assembled structures due to clustered DNA methylation
    ARC Discovery Projects
    Open grant
  • 2018 - 2022
    Integrating immunity and genetics in Follicular Lymphoma to establish a prognostic score fit for the modern era
    NHMRC Project Grant
    Open grant
  • 2018
    Queensland Bladder Cancer Initiative (PA Research Foundation Grant administered by the Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2016 - 2017
    QMUL Research Project 1
    Queen Mary University of London
    Open grant
  • 2016 - 2019
    Rapid detection and quantitation of Campylobacter jejuni/coli in processing.
    Queensland Department of Agriculture and Fisheries
    Open grant
  • 2016 - 2018
    AC electrohydrodynamics in microfluidic devices
    UniQuest Pty Ltd
    Open grant
  • 2016
    Does prostatic manipulation result in increased numbers and clusters of circulating tumour cells?
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2016
    Exosome and Bio/Nanoparticle Characterisation Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2018
    Trapping and Watching Biomolecular Complexes near Nanopores
    ARC Discovery Projects
    Open grant
  • 2014 - 2015
    Optimisation of the single drop genomics assay to detect food pathogens
    Australian Centre for International Agricultural Research
    Open grant
  • 2014 - 2016
    Tuneable 'Nano-Shearing': An Innovative Mechanism for the Accurate and Specific Capture of Cells and Molecules
    ARC Discovery Projects
    Open grant
  • 2013 - 2019
    Enabling Clinical Epigenetic Diagnostics: The Next Generation of Personalized Breast Cancer Care
    National Breast Cancer Foundation
    Open grant
  • 2012
    An intergrated fluidic circuit system for digital PCR analysis, single-cell gene- expression, and high-throughput preparation of next-generation sequencing libraries.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011
    Mass spectrometer for biomolecule discovery, structural analysis and quantification.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Fabrication and Testing Facilites for Mono-Dispersed Nanoporous Spheres in Advanced Bio-applications
    UQ Major Equipment and Infrastructure
    Open grant
  • 2009 - 2012
    Accelerated Molecular Probe Pipeline
    Seattle Biomedical Research Institute
    Open grant
  • 2008 - 2013
    Novel strategies for prediction and control of advanced breast cancer via nanoscaled epigenetic-based biosensors
    National Breast Cancer Foundation
    Open grant
  • 2008 - 2011
    Nanoscaled biosensors: reading epigenetic signatures to improve breast cancer detection and treatment
    Cancer Australia
    Open grant
  • 2008
    A high-throughput facility for the identification and analysis of gene regulatory elements and factors
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Advanced environmental and process analysis facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Automated Microvave Reactor for Polymer Chemistry, Materials Development and Nanotechnology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Quantitative Particle and Cell Size Distribution Facility: Accelerating the Development of Advanced Materials, Water Treamtnet and Mineral Processing at UQ
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008
    Solid State NMR Console
    UQ Major Equipment and Infrastructure
    Open grant
  • 2007 - 2010
    Novel Nanotechnology Platforms for Disease Biomarker Diagnostics
    Queensland Government Smart State National and International Research Alliances Program
    Open grant
  • 2007
    Early detection of breast cancer via nanoscaled biomarker discovery and diagnostics
    National Breast Cancer Foundation
    Open grant
  • 2006
    Real time PCR and nanoparticle diagnostic facilities for high-throughput quantitative analysis of genomic structure and gene expression
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2005 - 2007
    Multiplexed Molecular Reading of Protein Associations via Nanoscaled Devices
    ARC Discovery Projects
    Open grant
  • 2004 - 2009
    Beyond Microarrays: Nano-Scaled Devices for High Throughput Biomolecular Sensing
    ARC Federation Fellowships
    Open grant
  • 2004 - 2006
    DEST INNOVATION ACCESS PROGRAMME: INTERNATIONAL SCIENCE LINKAGES - OzNano2Life: Australian Nanobiotechnology Cluster Integrated with a European Union Network of Excellence
    University of Technology Sydney
    Open grant
  • 2003 - 2010
    ARC Centre of Excellence for Functional Nanomaterials (administered by UNSW from September 2012 onwards)
    ARC Centres of Excellence
    Open grant
  • 2003
    DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING
    ARC Discovery Projects
    Open grant
  • 1999
    Biomaterials and Nanotechnology Research Initiative
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 1999
    Designed nanostructured materials through bi-inspired assembly
    UQ External Support Enabling Grant
    Open grant
  • 1999 - 2001
    Designed nanostructures for Ti02-based solar cells
    Sustainable Technologies Australia
    Open grant
  • 1999 - 2001
    Designed nanostructures for Ti02-based solar cells
    Sustainable Technologies Australia
    Open grant
  • 1999 - 2001
    Self-assembled membranes for protection of foreign tissue transplants
    ARC Australian Research Council (Large grants)
    Open grant
  • 1998
    Mechanistic Studies of the Anti-HIV drug FP-21399
    UQ Foundation
    Open grant
  • 1998 - 2000
    Rapid DNA sequencing by hybridization of a patterned colloidal array
    ARC Australian Research Council (Large grants)
    Open grant
  • 1997
    Febrication of nanostructured ceramic materials and devices
    ARC Australian Research Council (Small grants)
    Open grant
  • 1997
    Rapid DNA sequencing by hybridization of a patterned colloidal array
    University of Queensland New Staff Research Grant
    Open grant

Availability

Professor Matt Trau is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Single-nanoparticle upconversion nanolasers for probing biological systems

    Principal Advisor

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Principal Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Single Molecule Readout of Immune Disfunction

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Towards n-plex quantification of molecular interactions for evolution-free biopanning

    Principal Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Utilising extracellular vesicles for the diagnosis of lung cancer.

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Digital Nanotechnologies to track molecular aberrations in cancer

    Principal Advisor

    Other advisors: Dr Richard Lobb, Dr Alain Wuethrich

  • Doctor Philosophy

    Utilising extracellular vesicles for the diagnosis of lung cancer.

    Principal Advisor

    Other advisors: Dr Alain Wuethrich, Dr Richard Lobb

  • Doctor Philosophy

    Single-nanoparticle upconversion nanolasers for probing biological systems

    Principal Advisor

  • Doctor Philosophy

    Chemical Reactions in Confined Systems

    Principal Advisor

    Other advisors: Professor Debra Bernhardt

  • Doctor Philosophy

    A nano-engineered chip to help manage acute and long-haul COVID-19 patients

    Principal Advisor

    Other advisors: Dr Alain Wuethrich

  • Doctor Philosophy

    Single molecule sensing on nanopillars: Reading complex molecular circuits

    Associate Advisor

    Other advisors: Dr Alain Wuethrich, Dr Abu Sina

  • Doctor Philosophy

    Development of next-generation molecular tools for diagnostics

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    A nano-map of cytokines in skin: Personalising treatment of skin inflammation by a digital nanotechnology

    Associate Advisor

    Other advisors: Associate Professor Mitchell Stark, Dr Alain Wuethrich

  • Doctor Philosophy

    The investigation of microglial activation in brain cancer and brain metastasis by an integrated nano-sensor

    Associate Advisor

    Other advisors: Dr Alain Wuethrich, Dr Richard Lobb

  • Doctor Philosophy

    Digital nanotechnologies for profiling trace immune dysregulations and tissue damage in emerging diseases

    Associate Advisor

    Other advisors: Dr Alain Wuethrich

  • Doctor Philosophy

    Advanced Micro and Nano Engineered Sensors for Post Translational Modification based Liquid Biopsy Analysis of Cancer

    Associate Advisor

    Other advisors: Dr Abu Sina, Dr Alain Wuethrich

  • Doctor Philosophy

    Surface engineering of nanoyeast

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    An integrated nano-bioengineered chip for enhanced molecular evolution

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    Investigating therapeutic potentials of brain-derived exosomes

    Associate Advisor

    Other advisors: Dr Christopher Howard, Dr Richard Lobb

  • Doctor Philosophy

    Development of next-generation molecular tools for diagnostics

    Associate Advisor

    Other advisors: Dr Christopher Howard

  • Doctor Philosophy

    A nano-map of cytokines in skin: Personalising treatment of skin inflammation by a digital nanotechnology

    Associate Advisor

    Other advisors: Associate Professor Mitchell Stark, Dr Alain Wuethrich

  • Doctor Philosophy

    Harnessing nanotechnology to unravel the phenotypic heterogeneity of extracellular vesicles

    Associate Advisor

    Other advisors: Dr Abu Sina, Associate Professor Mitchell Stark, Dr Alain Wuethrich

  • Master Philosophy

    Digital catalysis and digital chemistry

    Associate Advisor

    Other advisors: Dr Shuvashis Dey

  • Doctor Philosophy

    A potential pan-cancer diagnostic utilizing DNA methylation landscapes

    Associate Advisor

    Other advisors: Dr Abu Sina

  • Doctor Philosophy

    Digital nanotechnologies to unravel immune dysregulation in long COVID

    Associate Advisor

    Other advisors: Dr Alain Wuethrich

Completed supervision

Enquiries

Contact Professor Matt Trau directly for media enquiries about:

  • Biomarkers
  • Biosensors
  • Breast cancer
  • Cancer
  • Colloid science
  • Diagnostics cancer
  • Materials science
  • Medicine - personalised
  • Nanobiotechnology
  • Nanotechnology
  • Personalised medicine
  • Physical Chemistry
  • Preventative medicine
  • Surface science

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au